Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion.

Jeelani, Hafiz; Sheikh, Muhammad Mubbashir; Tahir, Nayha; Ying, Grace; Prasad, Sonika; Yaremko, Maryana; Gill, Jashan

Jeelani, Hafiz; Sheikh, Muhammad Mubbashir; Tahir, Nayha; Ying, Grace; Prasad, Sonika; Yaremko, Maryana; Gill, Jashan.

Afiliação

Jeelani H; Department of Medicine, Rosalind Franklin University/Chicago Medical School, North Chicago, Illinois, USA.
Sheikh MM; Department Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Tahir N; Department of Medicine, Rosalind Franklin University/Chicago Medical School, North Chicago, Illinois, USA.
Ying G; Department of Medicine, Rosalind Franklin University/Chicago Medical School, North Chicago, Illinois, USA.
Prasad S; Department of Medicine, Rosalind Franklin University/Chicago Medical School, North Chicago, Illinois, USA.
Yaremko M; Department of Medicine, Northwestern Medicine Mchenry Hospital, McHenry, Illinois, USA.
Gill J; Department of Medicine, Rosalind Franklin University/Chicago Medical School, North Chicago, Illinois, USA.

JACC Case Rep ; 4(12): 751-754, 2022 Jun 15.

Article em En | MEDLINE | ID: mdl-35734528

Palavras-chave

BTK, Bruton tyrosine kinase; CLL, chronic lymphocytic leukemia; DOAC, direct oral anticoagulant; TTE, transthoracic echocardiography; apixaban; chronic lymphocytic leukemia; ibrutinib; left atrial appendage occlusion; pericardial effusion

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JACC Case Rep Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JACC Case Rep Ano de publicação: 2022 Tipo de documento: Article